loader
Please Wait
Applying Filters...
menu
    • menu

    Looking for Controlled & Modified Release? Find poly dl lactic co glycolic acid for stability, solubility & bioavailability enhancement on PharmaCompass.

    gangwal-healthcare-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    View Presentation

    High-quality raw materials and custom blends for pharma, biopharma, nutrition, veterinary, and cosmetics worldwide.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Menu

    Poly-DL-Lactic-co-Glycolic Acid

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Nanjing Well Pharmaceutical

    02 2Nomisma Healthcare

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass

    01

    Nanjing Well Pharmaceutical

    China
    arrow
    CPhI China
    Booth #E3D78A
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Dosage Form : Solution

    Grade : Parenteral

    Brand Name : Polylactide-co-glycolide (8...

    Application : Controlled & Modified Release

    Excipient Details : Poly (lactide-co-glycolide) (80:20) is used as a sustained release material for drug delivery systems in injectable formulations.

    Pharmacopoeia Ref : ChP

    Technical Specs : NA

    Ingredient(s) : Poly-DL-Lactic-co-Glycolic Acid

    Dosage Form : Solution

    Grade : Parenteral

    arrow
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Ingredient(s) : Poly-DL-Lactic-co-Glycolic Acid

    Dosage Form : Solution

    Category : Controlled & Modified Release

    Brand : POLYLACTIDE-CO-GLYCOLIDE (80:20)

    Applications : Poly (lactide-co-glycolide) (80:20) is used as a sustained release material for drug delivery systems in injectable formulations.

    Pharmacopoeia Ref : ChP

    Technical Specs : NA

    Grade : Parenteral

    arrow
    Polylactide-co-glycolide (80:20)

    Excipients Web Link

    Virtual Booth

    02

    Nomisma Healthcare

    PLGA-PEG

    arrow
    PEGS Boston Summit
    Not Confirmed

    03

    Nomisma Healthcare

    PLGA

    arrow
    PEGS Boston Summit
    Not Confirmed

    Nomisma Healthcare

    India
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Tablet

    Grade : Oral, Parenteral

    Brand Name : PLGA

    Application : Controlled & Modified Release

    Excipient Details : PLGA (Poly (Lactic-Co-Glycolic Acid)) is a unique base polymer for controlled release of drugs & medical implant materials. It is biodegradable & biocompatible and since both monomers occur naturally it has minimal toxicity.

    Pharmacopoeia Ref : NA

    Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, available ratio PLGA 50:50, PLGA 75:25, PLGA 85:15, PLGA 55:45 Star Glucose, PLGA 65:35, PLGA 90:10.

    Ingredient(s) : Poly-DL-Lactic-co-Glycolic Acid

    Dosage Form : Tablet

    Grade : Oral, Parenteral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Poly-DL-Lactic-co-Glycolic Acid

    Dosage Form : Tablet

    Category : Controlled & Modified Release

    Brand : PLGA

    Applications : PLGA (Poly (Lactic-Co-Glycolic Acid)) is a unique base polymer for controlled release of drugs & medical implant materials. It is biodegradable & biocompatible and since both monomers occur naturally it has minimal toxicity.

    Pharmacopoeia Ref : NA

    Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, available ratio PLGA 50:50, PLGA 75:25, PLGA 85:15, PLGA 55:45 Star Glucose, PLGA 65:35, PLGA 90:10.

    Grade : Oral, Parenteral

    arrow
    blank

    Excipients Web Link

    Virtual Booth

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.